Annual survey monitoring HIV and hepatitis C prevalence, risk behaviours, and treatment uptake among people who inject drugs
The Australian Needle and Syringe Program Survey from the Kirby Institute provides serial point prevalence estimates of HIV and HCV antibody prevalence, HCV RNA prevalence and monitors sexual and injecting behaviour among PWID in Australia.
The ANSPS is conducted annually at more than 50 needle and syringe program (NSP) services over a one to two week period in October each year.
Findings highlight the benefits of investing in robust sentinel surveillance to monitor trends in drug use, sexual and injecting risk behaviour, treatment uptake and prevalence of blood-borne viral infections among PWID.
